Search Results - "Sleen, Yannick"
-
1
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2021)“…Objective Macrophages mediate inflammation, angiogenesis, and tissue destruction in giant cell arteritis (GCA). Serum levels of the macrophage‐associated…”
Get full text
Journal Article -
2
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2018)“…Giant cell arteritis (GCA) is an autoimmune vasculitis affecting large and medium‐sized arteries. Ample evidence indicates that GCA is a heterogeneous disease…”
Get full text
Journal Article -
3
Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis
Published in Arthritis care & research (2010) (01-09-2024)“…Objective Giant cell arteritis (GCA) is characterized by granulomatous inflammation of the medium‐ and large‐sized arteries accompanied by remodeling of the…”
Get full text
Journal Article -
4
Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster
Published in Arthritis care & research (2010) (01-01-2024)“…Objective Vaccination remains essential in preventing morbidity of SARS–CoV‐2 infections. We previously showed that >10 mg/day of prednisolone and methotrexate…”
Get full text
Journal Article -
5
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
Published in Clinical & translational immunology (2020)“…Objective To determine the presence and spatial distribution of different macrophage phenotypes, governed by granulocyte macrophage colony‐stimulating factor…”
Get full text
Journal Article -
6
Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
Published in Frontiers in immunology (15-06-2023)“…Research into giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) has become more important in the last few decades. Physicians are facing several…”
Get full text
Journal Article -
7
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Published in Seminars in arthritis and rheumatism (01-08-2022)“…•More than a quarter of patients with PMR may have subclinical GCA at diagnosis.•Meta-analysis of a large patients’ data set could not identify a marker for…”
Get full text
Journal Article -
8
Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-10-2023)“…Giant cell arteritis (GCA) affects almost exclusively individuals above 50 years old, suggesting a role of aging-related changes such as cellular senescence in…”
Get full text
Journal Article -
9
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
Published in Vaccine (24-03-2023)“…Previous interim data from a phase I study of AKS-452, a subunit vaccine comprising an Fc fusion of the respiratory syndrome coronavirus 2 (SARS-CoV-2) spike…”
Get full text
Journal Article -
10
Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial
Published in Nature communications (04-08-2024)“…Vaccine responsiveness is often reduced in older adults. Yet, our lack of understanding of low vaccine responsiveness hampers the development of effective…”
Get full text
Journal Article -
11
Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
Published in Rheumatology (Oxford, England) (06-07-2022)“…Abstract Objectives GCA is a large vessel vasculitis in which metabolically active immune cells play an important role. GCA diagnosis is based on CRP/ESR and…”
Get full text
Journal Article -
12
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
Published in Frontiers in immunology (22-08-2019)“…Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory diseases requiring long-term glucocorticoid treatment. Limited data on dynamics in…”
Get full text
Journal Article -
13
Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
Published in Scientific reports (26-07-2017)“…Monocytes/macrophages are critical in systemic and local inflammation in giant cell arteritis (GCA) and possibly in clinically overlapping polymyalgia…”
Get full text
Journal Article -
14
Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica
Published in Arthritis research & therapy (07-03-2022)“…Diagnosing patients with giant cell arteritis (GCA) remains difficult. Due to its non-specific symptoms, it is challenging to identify GCA in patients…”
Get full text
Journal Article -
15
Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
Published in Frontiers in immunology (02-08-2023)“…BackgroundGiant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) are overlapping inflammatory diseases. Antigen-presenting cells (APCs), including…”
Get full text
Journal Article -
16
Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients
Published in Frontiers in immunology (2023)“…Giant cell arteritis (GCA) is a vasculitis of the medium- and large-sized arteries. Interferon type I (IFN-I) is increasingly recognized as a key player in…”
Get full text
Journal Article -
17
Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica
Published in Frontiers in immunology (11-08-2022)“…Although polymyalgia rheumatica (PMR) is a very common rheumatic inflammatory disease, current insight into the pathobiology of PMR is limited and largely…”
Get full text
Journal Article -
18
Need and value of targeted immunosuppressive therapy in giant cell arteritis
Published in Rheumatic & musculoskeletal diseases open (01-02-2022)“…Despite the heterogeneity of the giant cell arteritis (GCA) at the level of clinical manifestations and the cellular and molecular players involved in its…”
Get full text
Journal Article Book Review -
19
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
Published in Frontiers in immunology (27-08-2024)“…Research has confirmed the safety and comparable seroconversion rates following SARS-CoV-2 vaccination in patients with solid cancers. However, the impact of…”
Get full text
Journal Article -
20
Frailty is related to serum inflammageing markers: results from the VITAL study
Published in Immunity & ageing (27-11-2023)“…Frailty describes an age-associated state in individuals with an increased vulnerability and less resilience against adverse outcomes. To score frailty,…”
Get full text
Journal Article